Acorda Therapeutics Higher Off Favorable Patent Ruling Related To Ampyra By: Benzinga via Benzinga March 09, 2017 at 15:55 PM EST Acorda Therapeutics Inc (NASDAQ: ACOR) shares are trading higher by $1.83 (6.7 percent) at $30.13 in Thursday's session. At 2:47 ... Read More >> Related Stocks: Acorda Therapeutics